Dr Burkhard Leeb, MD, - State Hospital Stockerau - Primarius Privat Dozent

Dr Burkhard Leeb

MD,

State Hospital Stockerau

Primarius Privat Dozent

Stockerau | Austria

Main Specialties: Internal Medicine, Rheumatology

ORCID logohttps://orcid.org/0000-0002-2368-5036


Top Author

Dr Burkhard Leeb, MD, - State Hospital Stockerau - Primarius Privat Dozent

Dr Burkhard Leeb

MD,

Introduction

Dr. Burkhard F. Leeb was born in Vienna in 1956, achieved his MD in 1981 and received his specialization in Internal Medicine in 1989, and in Rheumatology in 1994, respectively He was appointed director of the newly established center for rheumatology, Lower Austria, at Stockerau Hospital in 1999. In collaboration with his co-workers he was able to establish this institution in Austrian rheumatology within a relative short time period. Aside this occupation Dr. Leeb had the honor to serve as president of the Austrian society for rheumatology and rehabilitation between 2008 and 2010, as well as a member and also as co-convenor of several EULAR task-forces, amongst them the ones for osteoarthritis and gout. In 2010 he earned his postdoctoral lecture qualification from the Medical University of Graz, Austria. Since 2009 Burkhard Leeb serves as the chairman of the Austrian Registry for Biologics in the treatment of rheumatic diseases, BioReg. Currently he is also lecturer on rheumatology at the Karl Landsteiner University of Health Sciences, Krems, Austria. From February 2018 to March 2019 he is on a sabbatical year from his directorship.
Up to date Dr. Leeb has published more than 150 articles in peer reviewed journals, and in books, amongst them meta-analyses on chondroitin sulfate, and diacerein, EULAR response criteria for polymyalgia rheumatica, and a respective disease activity score. His main scientific interests are arthritides, polymyalgia rheumatica, as well as osteoarthritis and gout, above all the questions along with disease activity assessment and individualized patient treatment.


Primary Affiliation: State Hospital Stockerau - Stockerau , Austria

Specialties:

Research Interests:


View Dr Burkhard Leeb’s Resume / CV

Education

Jun 1994
Lainz Hospital, Center for Rheumatology
MD, consultant
Specialization in Rheumatology
Sep 1989
Lainz Hospital, 2 nd Dept. of Medicine
MD, resident
Specialization in Internal Medicine

Experience

Sep 2016
Roche Scientific Award
Nov 2009
Wyeth Scientific Award

Austrian Society for Rheumatology and Rehabilitation
Nov 2007
2nd Wyeth Scientific Award

Austrian Society for Rheumatology and Rehabilitation
Nov 2006
1st Wyeth Scientific Award

Austrian Society for Rheumatology and Rehabilitation,
Jun 2005
2nd Scientific Award

Medical Society of Lower Austria,

Publications

81Publications

872Reads

449Profile Views

37PubMed Central Citations

Biologika-Therapien in Österreich. Daten aus dem Österreichischen Biologika-Register BioReg

Akt Rheumatol DOI: 10.1055/a-0584-5830

Aktuelle Rheumatologie

The Austrian Registry for Biologicals in the Treatment of Inflammatory Rheumatic Diseases, BioReg, was founded in 2009, which is relatively late compared to other countries. As elsewhere, the registry aims to document tolerability and efficacy. BioReg was founded as a non-profit association, which implies that the inclusion of patients is voluntary, as in the German RABBIT registry. At the end of May 2017, a total of 2,132 patients had been included in the data base, of whom 1,157 patients suffered from rheumatoid arthritis (RA), 497 from spondylitis ankylosans (SpA), 401 from psoriatic arthritis (PsA), and 77 from other rheumatic diseases (SERE). In comparison to European colleagues, rheumatologists in Austria initiate bDMARDs in RA patients at high moderate disease activity. Functionality of patients under biological treatment can be preserved, which of course exerts a positive impact on working ability. No unusual adverse events were observed; the reported side effects are the expected ones, well known from clinical trials. The prescription rates for the single compounds are comparable with those reported in the German RABBIT registry, and the retention rates are generally similar. Registries such as BioReg show the hidden normal situation for the treatment of patients with inflammatory rheumatic diseases, and specifically contribute to quality management.

View Article
June 2018
4 Reads

The Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthritis: An Austrian NonInterventional Study.

Am J Arthritis Res. 2018; 2(1): 1012.

American Journal of Arthritis Research

Tocilizumab (TCZ) has variously been approved in combination with Methotrexate for the treatment of Rheumatoid Arthritis (RA) in adults. The objectives of this Non-Interventional Study (NIS) were to assess the efficacy and safety of TCZ in routine clinical use. Clinical response to TCZ was evaluated by collecting Disease Activity Score 28 (DAS28) and other efficacy parameters. The number and type of Adverse Events (AEs) and concomitant medication were documented. The median treatment duration was 52 weeks. The efficacy and safety analyses included 590 patients, 97.8% of whom had been pretreated with disease-modifying anti-rheumatic drugs. DAS28 scores were available for 484 patients, of whom 67.98% experienced disease remission and 83.06% low disease activity at any time during treatment. AEs were reported for 21.02% of the patients, with 10% serious events. The results confirm that TCZ is efficacious and well tolerated in routine use for the treatment of RA. As the results of this NIS are in line with existing data, a reevaluation of the risk-benefit balance of TCZ for the treatment of RA does not seem necessary.

View Article
June 2018
3 Reads

Comments on Alegría and Irarrázaval (2017): Is diacerein an alternative for the treatment of osteoarthritis?

Authors:
Burkhard Leeb

Medwave 2018 Apr 12;18(2):e7193. Epub 2018 Apr 12.

Second Department of Medicine, Competence Centre for Rheumatology Lower Austria, Federal State Clinical Center Stockerau, Landstrasse 18, 2000 Stockerau, Austria; Private office: A-2020 Hollabrunn, Babogasse 20. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5867/medwave.2018.02.7193DOI Listing
April 2018
10 Reads

Patient Reported Outcomes Compared to Composite Indexes in Routine Disease Activity Assessment of Rheumatoid Arthritis.

Authors:
Leeb BF

Am J Arthritis Res. 2017; 1(1): 1005.

American Journal of Arthritis Research

Editorial, no abstract available

View Article
July 2017
6 Reads

RADAI-5 and electronic monitoring tools.

Clin Exp Rheumatol 2016 Sep-Oct;34(5 Suppl 101):S5-S10. Epub 2016 Oct 18.

2nd Dept. of Medicine, Center for Rheumatology Lower Austria, Karl Landsteiner Institute for Clinical Rheumatology, State Hospital Stockerau, Austria.

View Article

Download full-text PDF

Source
February 2017
5 Reads
1 Citation
2.724 Impact Factor

The Short Form Score for the Assessment and Quantification of Chronic Rheumatic Affections of the Hands in Daily Clinical Routines-Its Sensitivity to Change and Preliminary Patient Relevant Variation Values: A Pilot Study.

Front Med (Lausanne) 2017 27;4. Epub 2017 Jan 27.

Second Department of Medicine, Center for Rheumatology, State Hospital Stockerau, Stockerau, Austria; Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria; Department for Rheumatology and Immunology, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2017.00006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269615PMC
January 2017
12 Reads

Should physicians' consider patient perception for modulating treatment?

Authors:
Burkhard F Leeb

Rheumatology (Oxford) 2016 11 21;55(11):1919-1920. Epub 2016 Jun 21.

2 Department of Medicine, Centre for Rheumatology, Lower Austria, State Hospital Stockerau, Karl Landsteiner Institute for Clinical Rheumatology, Stockerau

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew254DOI Listing
November 2016
3 Reads
4.475 Impact Factor

Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.

BMC Musculoskelet Disord 2016 10 3;17(1):412. Epub 2016 Oct 3.

Lower Austrian State Hospital Stockerau, 2nd Department for internal medicine, Lower Austrian Center for Rheumatology, Landstrasse 18, Stockerau, 2000, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-016-1270-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048649PMC
October 2016
7 Reads
1.898 Impact Factor

Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.

BMC Musculoskelet Disord 2016 08 22;17(1):358. Epub 2016 Aug 22.

Lower Austrian State Hospital Stockerau, 2nd Department for internal medicine, Lower Austrian Center for Rheumatology, Landstrasse 18, Stockerau, 2000, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-016-1207-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994324PMC
August 2016
4 Reads
2 Citations
1.898 Impact Factor

Smoking - Does It Affect Rheumatoid Arthritis Activity? Does It Matter?

J Rheumatol 2015 Jul;42(7):1072-4

2nd Department of Medicine, Center for Rheumatology, Lower Austria, State Hospital Stockerau; Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150491DOI Listing
July 2015
4 Reads
3.187 Impact Factor

Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey.

BMC Musculoskelet Disord 2015 May 6;16:109. Epub 2015 May 6.

Rheumatology and Immunology Division, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-015-0567-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427952PMC
May 2015
20 Reads
1.898 Impact Factor

Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA).

BMC Musculoskelet Disord 2015 Apr 1;16:73. Epub 2015 Apr 1.

2nd Department of Medicine, Center for Rheumatology, Lower Austria, State Hospital Stockerau, Karl Landsteiner Institute for Clinical Rheumatology, Landstrasse 18, A-2000, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-015-0512-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393861PMC
April 2015
11 Reads
1.898 Impact Factor

Quality of care of rural rheumatoid arthritis patients in Austria.

Wien Klin Wochenschr 2014 Jun 28;126(11-12):360-7. Epub 2014 Mar 28.

Rheumatologist in private practice, Freiung 19, 4600, Wels, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-014-0540-6DOI Listing
June 2014
6 Reads
0.791 Impact Factor

[Austrian 3e-recommendations for diagnosis and management of gout 2013].

Wien Klin Wochenschr 2014 Feb 3;126(3-4):79-89. Epub 2013 Dec 3.

State Hospital Stockerau, 2nd Medical Department,Lower Austrian Centre for Rheumatology, Karl Landsteiner Institute for Clin. Rheumatology, Landstraße 18, 2000, Stockerau, Österreich,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-013-0469-1DOI Listing
February 2014
8 Reads
0.791 Impact Factor

Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis.

Rheumatology (Oxford) 2013 Aug 16;52(8):1535-7. Epub 2013 Jan 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kes406DOI Listing
August 2013
3 Reads
4.475 Impact Factor

Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.

J Rheumatol 2013 Apr 1;40(4):394-400. Epub 2013 Feb 1.

Lower Austrian State Hospital Stockerau, Second Department for Internal Medicine, Lower Austrian Centre for Rheumatology, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.120952DOI Listing
April 2013
6 Reads
3.187 Impact Factor

Rituximab in psoriatic arthritis: an exploratory evaluation.

Ann Rheum Dis 2012 Nov 24;71(11):1868-71. Epub 2012 Jul 24.

Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2012-201897DOI Listing
November 2012
17 Reads
10.377 Impact Factor

A comparison of the modified score for the assessment of chronic rheumatoid affections of the hands and the australian/canadian osteoarthritis hand index in hand osteoarthritis patients.

Int J Rheumatol 2009 10;2009:249096. Epub 2009 Feb 10.

Lower Austrian Centre for Rheumatology, 2nd Department of Medicine, State Hospital Weinviertel Stockerau, 2000 Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/249096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809330PMC
July 2011
3 Reads

International position paper on febuxostat.

Clin Rheumatol 2010 Aug 17;29(8):835-40. Epub 2010 Apr 17.

Department of Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-010-1457-8DOI Listing
August 2010
30 Reads
10 Citations
1.774 Impact Factor

The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.

Clin Rheumatol 2010 Feb 11;29(2):167-74. Epub 2009 Nov 11.

Karl Landsteiner-Institute for Clinical Rheumatology, First and Second Department of Medicine, Center for Rheumatology, Lower Austria, State Hospital Stockerau, Landstrasse 18, Stockerau, 2000, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-009-1304-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797412PMC
February 2010
8 Reads
1.774 Impact Factor

A comparison of patient questionnaires and composite indexes in routine care of rheumatoid arthritis patients.

Joint Bone Spine 2009 Dec;76(6):658-64

1st and 2nd Department of Medicine, Center for Rheumatology, Lower Austria, State Hospital Stockerau, Karl Landsteiner-Institute for Clinical Rheumatology, Landstrasse 18, A-2000 Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2009.04.001DOI Listing
December 2009
16 Reads
2.901 Impact Factor

The rheumatoid arthritis disease activity index-5 in daily use. Proposal for disease activity categories.

J Rheumatol 2009 May 30;36(5):918-24. Epub 2009 Mar 30.

1st and 2nd Department of Medicine, Center for Rheumatology, Lower Austrian State Hospital, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.080863DOI Listing
May 2009
216 Reads
3.187 Impact Factor

Hotel-based rheumatology, and more.

Authors:
Burkhard F Leeb

J Rheumatol 2009 Feb;36(2):455-6; author reply 456-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.080818DOI Listing
February 2009
5 Reads
1 Citation
3.187 Impact Factor

[Austrian expert opinion on the standard for expert assessment of course of illness in patients with chronic polyarthritis (rheumatoid arthritis)].

Wien Klin Wochenschr 2008 ;120(7-8):234-41

Klinische Abteilung für Rheumatologie, Medizinische Universität Wien, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-008-0958-9DOI Listing
September 2008
10 Reads
0.791 Impact Factor

Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI.

J Rheumatol 2008 Jul 15;35(7):1294-9. Epub 2008 May 15.

1st and 2nd Department of Medicine, Center for Rheumatology, Lower Austria, Austria.

View Article

Download full-text PDF

Source
July 2008
2 Reads
11 Citations
3.187 Impact Factor

Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.

Curr Opin Rheumatol 2008 May;20(3):295-9

Division of Rheumatology, Department of Internal Medicine, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e3282ffdecaDOI Listing
May 2008
7 Reads
4.886 Impact Factor

On "Effectiveness of nonpharmacological and nonsurgical interventions..." Moe et al. Phys Ther. 2008;88: 1716-1727.

Phys Ther 2008 Mar;88(3):407-8; author reply 408

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2522/ptj.2008.88.3.407DOI Listing
March 2008
3 Reads
2.526 Impact Factor

Disease activity score-28 values differ considerably depending on patient's pain perception and sex.

J Rheumatol 2007 Dec 1;34(12):2382-7. Epub 2007 Nov 1.

2nd Department of Medicine, Center for Rheumatology, State Hospital Korneuburg-Stockerau, Karl Landsteiner Institute for Clinical Rheumatology; A-2000 Stockerau, Landstrasse 18, Austria.

View Article

Download full-text PDF

Source
December 2007
5 Reads
3.187 Impact Factor

The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.

Arthritis Rheum 2007 Jun;57(5):810-5

Lower Austrian Center for Rheumatology, State Hospital Stockerau, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://www.researchgate.net/profile/Burkhard_Leeb/publicatio
Web Search
http://ard.bmj.com/content/early/2008/05/13/ard.2008.088526.
Web Search
http://dx.doi.org/10.1002/art.22771DOI Listing
June 2007
12 Reads
7.764 Impact Factor

The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients.

Arthritis Rheum 2007 Mar;57(2):256-60

HUMANIS Klinikum Lower Austria, Lower Austrian Center for Rheumatology, Karl Landsteiner-Institute for Clinical Rheumatology, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.22531DOI Listing
March 2007
3 Reads
7.764 Impact Factor

Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Drugs Aging 2006 ;23(5):391-402

1st and 2nd Department of Medicine, Centre for Rheumatology, Humanisklinikum Lower Austria, Stockerau, Landstrasse, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002512-200623050-00003DOI Listing
December 2006
3 Reads
2.838 Impact Factor

Should physicians manipulate their assessment tools? No, they shouldn't!

Authors:
Burkhard F Leeb

J Rheumatol 2006 Nov;33(11):2359-60; author reply 2360-1

View Article

Download full-text PDF

Source
November 2006
2 Reads
3.187 Impact Factor

A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis.

Arch Intern Med 2006 Sep;166(17):1899-906

Second Department of Medicine, Lower Austrian Centre for Rheumatology, Humanis Klinikum Stockerau, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.166.17.1899DOI Listing
September 2006
5 Reads
17.333 Impact Factor

Intravenous application of omega-3 fatty acids in a patient with active spondylarthropathy--a case report.

Clin Rheumatol 2006 Jul 12;25(4):577-8. Epub 2005 Oct 12.

Second Department of Medicine, Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Stockerau, Landstrasse 18, A-2000, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-005-0027-yDOI Listing
July 2006
3 Reads
1.774 Impact Factor

Leflunomide/chloroquin combination therapy in rheumatoid arthritis: a pilot study.

Clin Rheumatol 2006 Jul 4;25(4):557-9. Epub 2006 Jan 4.

Second Department of Medicine, HUMANIS Klinikum Lower Austria, Lower Austrian Center for Rheumatology, A-2000, Stockerau, Landstrasse 18, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-005-0149-2DOI Listing
July 2006
3 Reads
1.774 Impact Factor

Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study.

Lipids 2006 Jan;41(1):29-34

Second Department of Medicine, Lower Austrian Center for Rheumatology, Humanisklinikum Lower Austria, Stockerau, Austria.

View Article

Download full-text PDF

Source
January 2006
9 Reads
1.854 Impact Factor

Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.

Ann Rheum Dis 2005 Apr 2;64(4):564-8. Epub 2004 Sep 2.

Second Department of Medicine, Lainz Hospital, Wolkersbergenstr 1, A-1130 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ard.2003.014985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755459PMC
April 2005
2 Reads
10.377 Impact Factor

The patient's perspective and rheumatoid arthritis disease activity indexes.

Rheumatology (Oxford) 2005 Mar 30;44(3):360-5. Epub 2004 Nov 30.

Second Department of Medicine, Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keh484DOI Listing
March 2005
5 Reads
4.475 Impact Factor

Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine.

Arthritis Rheum 2005 Feb;53(1):56-60

Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.20923DOI Listing
February 2005
8 Reads
7.764 Impact Factor

The DAS28 in rheumatoid arthritis and fibromyalgia patients.

Rheumatology (Oxford) 2004 Dec 13;43(12):1504-7. Epub 2004 Jul 13.

Second Department of Medicine, HUMANIS Klinikum Lower Austria, Lower Austrian Center for Rheumatology, A-2000 Stockerau, Landstrasse 18, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keh322DOI Listing
December 2004
3 Reads
4.475 Impact Factor

Development of the M-SACRAH, a modified, shortened version of SACRAH (Score for the Assessment and Quantification of Chronic Rheumatoid Affections of the Hands).

Rheumatology (Oxford) 2004 Nov 10;43(11):1409-13. Epub 2004 Aug 10.

Second Department of Medicine, Landstrasse 18, Humanis Klinikum, Stockerau, Lower Austrian Centre for Rheumatology, A-2000.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keh360DOI Listing
November 2004
6 Reads
4.475 Impact Factor

A disease activity score for polymyalgia rheumatica.

Authors:
B F Leeb H A Bird

Ann Rheum Dis 2004 Oct;63(10):1279-83

2nd Department of Medicine, Lower Austrian Centre for Rheumatology, Endocrinology, Humanisklinikum Lower Austria, A-2000 Stockerau, Landstrasse 18, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ard.2003.011379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754762PMC
October 2004
3 Reads
10.377 Impact Factor

[Treatment of osteoarthritis of the knee joint. Efficacy and tolerance to acemetacin slow release in comparison to celecoxib].

Orthopade 2004 Sep;33(9):1032-41

II. Medizinische Abteilung, NO-Zentrum für Rheumatologie, Humanis-Klinikum Niederösterreich, Landstrasse 18, 2000 Stockerau, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00132-004-0670-zDOI Listing
September 2004
5 Reads
0.665 Impact Factor

[Rheumatology--a dynamic discipline].

Authors:
Burkhard F Leeb

Wien Med Wochenschr 2003 ;153(13-14):290

View Article

Download full-text PDF

Source
January 2004
5 Reads

[Biologicals in treatment of rheumatoid arthritis and other inflammatory arthropathies].

Wien Med Wochenschr 2003 ;153(13-14):304-8

II. Medizinischen Abteilung, NO Zentrum für Rheumatologie, Humanisklinikum Niederösterreich, Landstrasse 18, A-2000 Stockerau.

View Article

Download full-text PDF

Source
January 2004
4 Reads

EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).

Ann Rheum Dis 2003 Dec;62(12):1189-94

Lower Austrian Centre for Rheumatology, Humanis Klinikum Lower Austria, Stockerau, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754412PMC
December 2003
11 Reads
10.377 Impact Factor

SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands.

Rheumatology (Oxford) 2003 Oct 30;42(10):1173-8. Epub 2003 May 30.

Second Department of Medicine, Humanisklinikum Lower Austria, Lower Austrian Center for Rheumatology, Stockerau.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keg319DOI Listing
October 2003
3 Reads
4.475 Impact Factor

Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis.

Clin Exp Rheumatol 2003 Jan-Feb;21(1):27-32

Division of Oncology, Department of Internal Medicine I, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
June 2003
3 Reads
2.724 Impact Factor

Glucosamine and chondroitin sulfate for the treatment of osteoarthritis: comment on the article by Akama and Saito.

Authors:
B F Leeb

Arthritis Rheum 2001 Dec;45(6):537-8

View Article

Download full-text PDF

Source
December 2001
3 Reads
7.764 Impact Factor

Management of knee osteoarthritis.

Authors:
B F Leeb

Ann Rheum Dis 2001 Oct;60(10):984

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1753391PMC
October 2001
3 Reads
10.377 Impact Factor

[Anti-TNF-alpha therapy as a new option in treatment of rheumatoid arthritis?].

Authors:
B F Leeb J Sautner

Wien Med Wochenschr 1999 ;149(19-20):554-7

Niederösterreichischen Zentrum für Rheumatologie am a. ö. Krankenhaus Stockerau.

View Article

Download full-text PDF

Source
May 2000
3 Reads

A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis.

J Rheumatol 2000 Jan;27(1):205-11

Lower Austrian Center for Rheumatology, Stockerau Hospital, Austria.

View Article

Download full-text PDF

Source
January 2000
5 Reads
3.187 Impact Factor

T cell derived cytokines in psoriatic arthritis synovial fluids.

Ann Rheum Dis 1998 Nov;57(11):691-3

Ludwig Boltzmann Institute of Rheumatology and Balneology, Vienna-Oberlaa, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1752505PMC
November 1998
3 Reads
10.377 Impact Factor

Early arthritis therapy: rationale and current approach.

J Rheumatol Suppl 1998 Jul;53:13-9

Department of Internal Medicine III, University of Vienna, Austria.

View Article

Download full-text PDF

Source
July 1998
3 Reads

Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.

J Rheumatol 1998 Jan;25(1):105-10

Ludwig Boltzmann Institute of Rheumatology, Vienna-Oberlaa, Austria.

View Article

Download full-text PDF

Source
January 1998
3 Reads
3.187 Impact Factor

[Results of a multicenter study of chondroitin sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints].

Wien Med Wochenschr 1996 ;146(24):609-14

Facharztpraxis für Innere Medizin-Rheumatologie, Hollabrunn.

View Article

Download full-text PDF

Source
April 1997
12 Reads

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.

J Rheumatol 1997 Mar;24(3):518-23

Ludwig Boltzmann Institute of Rheumatology, Vienna-Oberlaa, Austria.

View Article

Download full-text PDF

Source
March 1997
5 Reads
3.187 Impact Factor

Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.

Clin Exp Rheumatol 1996 Jul-Aug;14(4):381-6

Ludwig Boltzmann Institute of Rheumatology and Balneology, Vienna-Oberlaa, Austria.

View Article

Download full-text PDF

Source
January 1997
3 Reads
2.724 Impact Factor

[Diagnosis and therapy of chronic polyarthritis].

Radiologe 1996 Aug;36(8):657-62

II. Medizinische Abteilung, Krankenhaus der Stadt Wien-Lainz, Wien.

View Article

Download full-text PDF

Source
August 1996
4 Reads
0.414 Impact Factor

Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.

Clin Exp Rheumatol 1995 Jul-Aug;13(4):459-63

Second Dept. of Medicine, Lainz Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
December 1995
3 Reads
2.724 Impact Factor

Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization.

AJR Am J Roentgenol 1995 Sep;165(3):585-92

Department of Radiology, Krankenhaus Lainz, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.165.3.7645475DOI Listing
September 1995
3 Reads
2.731 Impact Factor

Diagnostic use of office-based ultrasound. Baker's cyst of the right knee joint.

Arthritis Rheum 1995 Jun;38(6):859-61

Second Department of Medicine, Lainz Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
June 1995
3 Reads
7.764 Impact Factor

Should folate supplementation be routinely recommended for older patients receiving methotrexate?

Authors:
B F Leeb

Drugs Aging 1994 Nov;5(5):319-22

2nd Department of Medicine, Center for Rheumatic Diseases, Lainz Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002512-199405050-00001DOI Listing
November 1994
3 Reads
2.838 Impact Factor

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Lancet 1994 Oct;344(8930):1105-10

Kennedy Institute of Rheumatology, Hammersmith, London, UK.

View Article

Download full-text PDF

Source
October 1994
3 Reads
45.217 Impact Factor

High free and latent collagenase activity in psoriatic arthritis synovial fluids.

Br J Rheumatol 1994 Aug;33(8):702-6

Ludwig Boltzmann Institute of Rheumatology and Balneology, Vienna-Oberlaa, Austria.

View Article

Download full-text PDF

Source
August 1994
3 Reads

[Topical felbinac in therapy of athletic injuries].

Authors:
B Leeb

Fortschr Med 1994 Feb;112(6):77-80

II. Medizinische Abteilung, Krankenhaus Lainz, Wien.

View Article

Download full-text PDF

Source
February 1994
3 Reads

[Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].

Acta Med Austriaca 1988 ;15(5):140-4

II. Medizinischen Abteilung, Zentrum für Diagnostik und Therapie rheumatischer Erkrankungen, Krankenhauses der Stadt Wien-Lainz.

View Article

Download full-text PDF

Source
March 1989
5 Reads